Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Home
Suven Life Sciences Limited
Press Release Oct 30 2023
Business
Oct 30 2023
5 min read

Press Release Oct 30 2023

Suven Life Sciences Limited has informed the Exchange regarding a press release dated October 30, 2023, titled "Suven Life Sciences announces Positive Topline Results from a Phase-2 study evaluating Samelisant (SUVN-G3031) for Excessive Daytime Sleepiness (EDS) in adult Narcolepsy patients with and without cataplexy".

View Attachment